Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Dyne Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 169 | 2 | 193 | +26 |
| Shares | 95.4M | 36.7K | 111.0M | +15.6M (+16.4%) |
| Value | $2.71B | $1.04M | $3.92B | +$1.21B (+44.7%) |
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (47)
Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (21)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Nantahala Capital Management, LLC | 435,256 | $12.4M |
| Qube Research & Technologies Ltd | 100,656 | $2.86M |
| Superstring Capital Management LP | 99,822 | $2.83M |
| Cubist Systematic Strategies, LLC | 42,817 | $1.22M |
| American International Group, Inc. | 29,138 | $827.2K |
| Jump Financial, LLC | 27,382 | $777.4K |
| Marex Group plc | 25,500 | $723.9K |
| Capstone Investment Advisors, LLC | 20,248 | $574.8K |
| Concurrent Investment Advisors, LLC | 20,200 | $573.5K |
| GTS Securities LLC | 18,613 | $528.4K |
| Millennium Management LLC | 18,011 | $511.3K |
| LPL Financial LLC | 15,114 | $429.1K |
| Natixis | 14,000 | $397.5K |
| Redmond Asset Management, LLC | 12,500 | $354.9K |
| Deerfield Management Company, L.P. (Series C) | 7,940 | $225.4K |
| Metropolitan Life Insurance Co | 3,137 | $89.1K |
| Belvedere Trading LLC | 1,807 | $51.3K |
| Allspring Global Investments Holdings, LLC | 1,210 | $34.4K |
| Truvestments Capital LLC | 464 | $13.2K |
| ADAR1 Capital Management, LLC | 297 | $8.43K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 9 | $255 |
Not filed for Q2 2024 yet (2)
Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 36,383 | $1.03M |
| Cutler Group LP | 300 | $8.00K |